An Open-Labeled, Randomized Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE in Patients With Relapsed Multiple Myeloma Who Have Failed Four or More Lines of Therapy
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Expanded access; Therapeutic Use
- Sponsors Takeda Oncology
- 19 Jun 2017 New trial record